SAGE Journals
Browse
CEP864132_Supplemental_material_tables.pdf (247.83 kB)

CEP864132 Supplemental material tables - Supplemental material for Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)

Download (247.83 kB)
journal contribution
posted on 2019-11-18, 07:06 authored by Jan Lewis Brandes, Suzanne Klise, John H Krege, Michael Case, Rashna Khanna, Raghavendra Vasudeva, Joel Raskin, Eric M Pearlman, David Kudrow

Supplemental material, CEP864132 Supplemental material tables for Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study) by Jan Lewis Brandes, Suzanne Klise, John H Krege, Michael Case, Rashna Khanna, Raghavendra Vasudeva, Joel Raskin, Eric M Pearlman and David Kudrow in Cephalalgia

Funding

Eli Lilly and Company

History